YOKE
Yoke Core ETF
Yoke Core ETF seeks to provide investors with long-term capital appreciation by investing in a diversified portfolio of growth-oriented companies that align with its thematic focus on innovative and sustainable sectors.
US
EQUITY
Active
MANAGEMENT STYLE
$ 237.0 M
ASSETS UNDER MGMT
42 bp
EXPENSES
Fund Basics
| Inception date | Feb 21, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ALPHABET INC. CLASS A | 4.7 % |
| EMCOR GROUP INC | 4.1 % |
| NVIDIA CORP | 3.8 % |
| ROLLS-ROYCE HOLDINGS-SP ADR | 3.6 % |
| WW GRAINGER INC | 3.4 % |
| ASML HOLDING NV-NY REG SHS | 3.4 % |
| TJX COMPANIES INC | 3.3 % |
| JOHNSON & JOHNSON | 3.1 % |
| EBAY INC | 3.0 % |
| NOVARTIS AG-ADR | 2.8 % |
Constituent Breakdown
| Number of holdings | 51 |
| Herfindahl-Hirschman Index | 236 |
| Wgt avg mkt cap (mns) | $807,009 |
| Large cap (>$10bn) | 99.5% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.6% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 87.1 % |
 |
BRITAIN | 5.2 % |
 |
NETHERLANDS | 3.4 % |
 |
SWITZERLAND | 2.8 % |
 |
IRELAND | 1.1 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 16.8% | 20.5% | -- | -- | -- | -- | -- | 18.5% |
| Dividend Yield | 0.5% | 1.0% | -- | -- | -- | -- | -- | 1.0% |
| Total Returns | 17.3% | 21.5% | -- | -- | -- | -- | -- | 19.5% | Ann. Volatility | 17.2% | 14.7% | -- | -- | -- | -- | -- | 17.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.00 | 77% |
| MSCI EAFE | 0.76 | 66% |
| MSCI Emg Mkts | 0.48 | 64% |
Liquidity Measures
| Avg. volume (000) | 7 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.07% |
Technical Indicators
| 30d moving avg. (EMA) | $31.62 |
| Relative strength (RSI) | 53 |
| MACD/Signal | -0.09/-0.07 |
| Bollinger Bands (Upper/Lower) | $32.20/$31.07 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. YOKE |
Expenses vs. YOKE |
ALTAR Score™ vs. YOKE |
|---|---|---|---|---|
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 32.0% | -23 bp | +1.2% |
| OEI | Optimized Equity Income ETF | 31.7% | +33 bp | -0.2% |
| FLQL | Franklin LibertyQ U.S. Equity ETF | 31.5% | -27 bp | +0.8% |
| QUAL | iShares MSCI USA Quality Factor ETF | 31.4% | -27 bp | +0.6% |
| SFTY | Horizon Managed Risk ETF | 31.4% | +35 bp | -0.4% |
| STOX | Horizon Core Equity ETF | 31.3% | +28 bp | -0.3% |
| USMC | Principal U.S. Mega-Cap ETF | 31.3% | -30 bp | -0.3% |
| LVDS | JPMorgan Fundamental Data Science Large Value ETF | 31.3% | +7 bp | +0.7% |
| RAYD | Rayliant Quantitative Developed Market Equity ETF | 31.1% | +38 bp | +0.1% |
| OMFL | Invesco Russell 1000 Dynamic Multifactor ETF | 30.6% | -13 bp | +0.3% |
Risk and Returns: YOKE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/9/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.4%
ALTAR SCORE™
35th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. YOKE's ALTAR Score™ is approximately -0.4 standard
deviations above the category average. This places YOKE in the 35th percentile
among funds in the category.
Sell-Side Consensus
$33.23
PRICE TARGET
+3.2%
UPSIDE